Browsing by Author "Gazzinelli, Ricardo Tostes"
Now showing items 21-40 of 168
-
Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection
Belew, Ashton Trey et al. | Date Issued: 2017 -
Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage
Hojo-Souza, Natália Satchiko et al. | Date Issued: 2020 -
Cooperative Activation of TLR2 and Bradykinin B2 Receptor Is Required for Induction of Type 1 Immunity in a Mouse Model of Subcutaneous Infection byTrypanosoma cruzi
Monteiro, Ana Carolina et al. | Date Issued: 2006 -
Cutting Edge: Plasmodium falciparum Induces Trained Innate Immunity
Schrum, Jacob E. et al. | Date Issued: 2018 -
Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection
Bafica, Andre Luiz Barbosa et al. | Date Issued: 2006 -
CXCR3 chemokine receptor contributes to specific CD8+ T cell activation by pDC during infection with intracellular pathogens
Ferreira, Camila Pontes et al. | Date Issued: 2020 -
CXCR3 chemokine receptor guides Trypanosoma cruzi-specific T-cells triggered by DNA/adenovirus ASP2 vaccine to heart tissue after challenge
Ferreira, Camila Pontes et al. | Date Issued: 2019 -
CXCR3 chemokine receptor guides Trypanosoma cruzi-specific T-cells triggered by DNA/adenovirus ASP2 vaccine to heart tissue after challenge
Ferreira, Camila Pontes et al. | Date Issued: 2019 -
Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes
Junqueira, Caroline Furtado et al. | Date Issued: 2018 -
Daily Rhythms of TNFα Expression and Food Intake Regulate Synchrony of Plasmodium Stages with the Host Circadian Cycle
Hirako, Isabella Cristina et al. | Date Issued: 2018 -
Desenvolvimento de uma vacina para COVID-19 baseada em plasmídeo recombinante como vetor vacinal e avaliação da eficácia em modelos experimentais.
de Azevedo, Patrick Orestes | Date Issued: 2024O surgimento da pandemia causada pelo coronavírus SARS-CoV-2 impulsionou o rápido desenvolvimento de vacinas que fossem capazes de contribuir para diminuição do número de casos e de mortalidade provocada pela doença ... -
Desenvolvimento e padronização de novas metodologias aplicadas ao diagnóstico e monitoração de cura da Esquistossomose Mansoni na fase inicial (aguda) e crônica
Queiroz, Rafaella Fortini Grenfell e | Date Issued: 2012Neste projeto, foram testados diferentes antígenos candidatos a padronização de novos métodos diagnósticos a serem usados nas diferentes fases da infecção esquistossomótica. Inicialmente, foram analisados os antígenos ... -
Designing recombinant MVAs as dual-antigen vector vaccines against SARS-CoV-2
Doro, Daniel et al. | Date Issued: 2021 -
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated
Sérgio, Sarah Aparecida Rodrigues et al. | Date Issued: 2022 -
Development and comparison of potential DNA and mRNA vaccines for Dengue serotype 2
Sérgio, Sarah Aparecida Rodrigues et al. | Date Issued: 2023 -
Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19
Bagno, Flávia Fonseca et al. | Date Issued: 2022 -
Development of a rapid test for detection of anti-COVID-19 IgG and IgM antibodies
Lopes, Thiciany Blener et al. | Date Issued: 2021 -
Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
Castro, Júlia T. et al. | Date Issued: 2021 -
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
Azevedo, Patrick Orestes et al. | Date Issued: 2023 -
Differential Use of TLR2 and TLR9 in the Regulation of Immune Responses during the Infection with Trypanosoma cruzi
Gravina, Humberto Doriguêtto et al. | Date Issued: 2013